Insider: Schuth Alexander O. COFO and Secretary - Denali Therapeutics Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 282,828 | 539,307 | 822,135 |
| Value | $5,566,055.04 | $10,613,561.76 | $16,179,616.80 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/06/2026 | DDS | 17,218 | Direct | COM | $16.50 | $284,097.00 | 282,828 |
| 08/12/2025 | DDS | 2,937 | Direct | COM | $13.58 | $39,884.46 | 242,346 |
| 01/07/2025 | DDS | 2,907 | Direct | COM | $20.81 | $60,494.67 | 244,308 |
| 01/06/2025 | DDS | 12,255 | Direct | COM | $20.22 | $247,796.10 | 247,215 |
| 11/07/2024 | DDS | 12,333 | Direct | COM | $29.68 | $366,043.44 | 181,291 |
| 11/07/2024 | DDS | 2,925 | Direct | COM | $30.72 | $89,856.00 | 178,366 |
| 11/07/2024 | DDS | 300 | Direct | COM | $31.29 | $9,387.00 | 178,066 |
| 08/21/2024 | DDS | 2,547 | Direct | COM | $24.78 | $63,114.66 | 178,066 |
| 08/20/2024 | DDS | 2,453 | Direct | COM | $23.79 | $58,356.87 | 183,966 |
| 08/20/2024 | DDS | 3,353 | Direct | COM | $23.54 | $78,929.62 | 180,613 |
| 08/13/2024 | DDS | 2,272 | Direct | COM | $22.89 | $52,006.08 | 186,419 |
| 02/14/2024 | DDS | 20,128 | Direct | COM | $17.66 | $355,460.48 | 187,341 |
| 02/13/2024 | DDS | 2,716 | Direct | COM | $17.29 | $46,959.64 | 207,469 |
| 01/05/2024 | DDS | 9,972 | Indirect | COM | $19.43 | $193,755.96 | 539,307 |
| 08/23/2023 | DDS | 2,522 | Indirect | COM | $23.17 | $58,434.74 | 518,989 |
| 08/21/2023 | DDS | 2,478 | Indirect | COM | $22.59 | $55,978.02 | 521,511 |
| 08/14/2023 | DDS | 2,772 | Indirect | COM | $23.67 | $65,613.24 | 518,989 |
| 08/10/2023 | DDS | 2,853 | Indirect | COM | $24.18 | $68,985.54 | 521,761 |
| 07/18/2023 | DDS | 9,702 | Indirect | COM | $30.01 | $291,157.02 | 518,989 |
| 07/17/2023 | DDS | 10,000 | Indirect | COM | $29.60 | $296,000.00 | 528,691 |
| 05/15/2023 | DDS | 9,200 | Indirect | COM | $28.55 | $262,660.00 | 529,491 |
| 05/15/2023 | DDS | 800 | Indirect | COM | $29.23 | $23,384.00 | 528,691 |
| 04/13/2023 | DDS | 4,898 | Indirect | COM | $25.04 | $122,645.92 | 528,691 |
| 04/12/2023 | DDS | 5,102 | Indirect | COM | $25.04 | $127,754.08 | 528,691 |
| 02/13/2023 | DDS | 3,497 | Indirect | COM | $30.09 | $105,224.73 | 528,691 |
| 1 2 3 4 5 Next Last You are at page 1 of 5 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research